Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sildenafil for Early Pulmonary Vascular Disease in Scleroderma

NCT04797286 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT04797286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04797286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sildenafil for Early Pulmonary Vascular Disease in Scleroderma
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Recruiting
Start date
September 20, 2021
Completion date
November 1, 2026
Enrollment
30 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

mildly elevated pulmonary pressures, scleroderma